Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma

Marcela Lonngi,1 Samuel K Houston,1 Timothy G Murray,1&ndash;3 Robert A Sisk,4 Christina L Decatur,1 Milena Cavalcante,1 Arnold M Markoe31Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USA; 2Murray Ocular Oncology and Reti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lonngi M, Houston SK, Murray TG, Sisk RA, Decatur CL, Cavalcante M, Markoe AM
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/fe2479ce397c40d8943273e8b09eab02
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fe2479ce397c40d8943273e8b09eab02
record_format	dspace
spelling	oai:doaj.org-article:fe2479ce397c40d8943273e8b09eab022021-12-02T07:01:50ZMicroincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma1177-54671177-5483https://doaj.org/article/fe2479ce397c40d8943273e8b09eab022013-02-01T00:00:00Zhttp://www.dovepress.com/microincisional-vitrectomy-for-retinal-detachment-in-i-125-brachythera-a12311https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Marcela Lonngi,1 Samuel K Houston,1 Timothy G Murray,1&ndash;3 Robert A Sisk,4 Christina L Decatur,1 Milena Cavalcante,1 Arnold M Markoe31Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USA; 2Murray Ocular Oncology and Retina, Miami, FL, USA; 3Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA; 4Department of Ophthalmology, Cincinnati Eye Institute, Cincinnati, OH, USAPurpose: To analyze functional and anatomical outcomes following 23/25+ gauge microincisional pars plana vitrectomy surgery (MIVS) in patients with radiation-related retinal detachment after successful 125-iodine (I-125) brachytherapy treatment for malignant uveal melanoma.Patients and methods: Retrospective case series of 102 consecutive eyes of 102 patients with history of uveal melanoma treated with I-125 brachytherapy that underwent MIVS at the Bascom Palmer Eye Institute. All cases were evaluated for surgical complications and local tumor control. Extended follow-up included Snellen&rsquo;s best-corrected visual acuity, intraocular pressure evaluation, quantitative echography, indirect ophthalmoscopy, and fundus imaging with optical coherence tomography/wide-field photography.Results: All patients had radiation-related complications, including retinal detachment (102 eyes), vasculopathy (91 eyes), optic neuropathy (32 eyes), and/or vitreous hemorrhage (8 eyes). Sixty-seven patients had vitreoretinal traction. Average follow-up after MIVS was 19.5 months, and from plaque removal was 57.7 months. Interval from plaque to MIVS was 38.1 months. Initial visual acuity was 20/258, which improved to 20/101 at 1 month, 20/110 at 3 months, 20/116 at 6 months, and 20/113 at 12 months (P &lt; 0.05). No eyes required enucleation. Melanoma-related mortality was 0.9% (1/102). There was no intra- or extraocular tumor dissemination, and no tumor recurrence.Conclusion: MIVS was effective in improving visual function and anatomy in patients with radiation-related retinal detachment. Tumors decreased in size and there was no evidence of recurrence or tumor dissemination. This combined procedure addresses the modifiable causes of visual loss in patients with previously treated malignant uveal melanoma and has the potential to enhance their visual function.Keywords: retinal detachment, vitrectomy, melanoma, radiation-related complicationsLonngi MHouston SKMurray TGSisk RADecatur CLCavalcante MMarkoe AMDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2013, Iss default, Pp 427-435 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Lonngi M Houston SK Murray TG Sisk RA Decatur CL Cavalcante M Markoe AM Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
description	Marcela Lonngi,1 Samuel K Houston,1 Timothy G Murray,1&ndash;3 Robert A Sisk,4 Christina L Decatur,1 Milena Cavalcante,1 Arnold M Markoe31Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USA; 2Murray Ocular Oncology and Retina, Miami, FL, USA; 3Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA; 4Department of Ophthalmology, Cincinnati Eye Institute, Cincinnati, OH, USAPurpose: To analyze functional and anatomical outcomes following 23/25+ gauge microincisional pars plana vitrectomy surgery (MIVS) in patients with radiation-related retinal detachment after successful 125-iodine (I-125) brachytherapy treatment for malignant uveal melanoma.Patients and methods: Retrospective case series of 102 consecutive eyes of 102 patients with history of uveal melanoma treated with I-125 brachytherapy that underwent MIVS at the Bascom Palmer Eye Institute. All cases were evaluated for surgical complications and local tumor control. Extended follow-up included Snellen&rsquo;s best-corrected visual acuity, intraocular pressure evaluation, quantitative echography, indirect ophthalmoscopy, and fundus imaging with optical coherence tomography/wide-field photography.Results: All patients had radiation-related complications, including retinal detachment (102 eyes), vasculopathy (91 eyes), optic neuropathy (32 eyes), and/or vitreous hemorrhage (8 eyes). Sixty-seven patients had vitreoretinal traction. Average follow-up after MIVS was 19.5 months, and from plaque removal was 57.7 months. Interval from plaque to MIVS was 38.1 months. Initial visual acuity was 20/258, which improved to 20/101 at 1 month, 20/110 at 3 months, 20/116 at 6 months, and 20/113 at 12 months (P &lt; 0.05). No eyes required enucleation. Melanoma-related mortality was 0.9% (1/102). There was no intra- or extraocular tumor dissemination, and no tumor recurrence.Conclusion: MIVS was effective in improving visual function and anatomy in patients with radiation-related retinal detachment. Tumors decreased in size and there was no evidence of recurrence or tumor dissemination. This combined procedure addresses the modifiable causes of visual loss in patients with previously treated malignant uveal melanoma and has the potential to enhance their visual function.Keywords: retinal detachment, vitrectomy, melanoma, radiation-related complications
format	article
author	Lonngi M Houston SK Murray TG Sisk RA Decatur CL Cavalcante M Markoe AM
author_facet	Lonngi M Houston SK Murray TG Sisk RA Decatur CL Cavalcante M Markoe AM
author_sort	Lonngi M
title	Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
title_short	Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
title_full	Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
title_fullStr	Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
title_full_unstemmed	Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
title_sort	microincisional vitrectomy for retinal detachment in i-125 brachytherapy-treated patients with posterior uveal malignant melanoma
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/fe2479ce397c40d8943273e8b09eab02
work_keys_str_mv	AT lonngim microincisionalvitrectomyforretinaldetachmentini125brachytherapytreatedpatientswithposterioruvealmalignantmelanoma AT houstonsk microincisionalvitrectomyforretinaldetachmentini125brachytherapytreatedpatientswithposterioruvealmalignantmelanoma AT murraytg microincisionalvitrectomyforretinaldetachmentini125brachytherapytreatedpatientswithposterioruvealmalignantmelanoma AT siskra microincisionalvitrectomyforretinaldetachmentini125brachytherapytreatedpatientswithposterioruvealmalignantmelanoma AT decaturcl microincisionalvitrectomyforretinaldetachmentini125brachytherapytreatedpatientswithposterioruvealmalignantmelanoma AT cavalcantem microincisionalvitrectomyforretinaldetachmentini125brachytherapytreatedpatientswithposterioruvealmalignantmelanoma AT markoeam microincisionalvitrectomyforretinaldetachmentini125brachytherapytreatedpatientswithposterioruvealmalignantmelanoma
_version_	1718399673049284608

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma

Ejemplares similares